论文信息 - Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies. - 字舞流文

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies.

T. Olsson | F. Piehl | A. Langer-Gould | J. Hillert | A. Fogdell-Hahn | J. Salzer | A. Svenningsson | J. Burman | J. Lycke | P. Nilsson | M. Vrethem | K. Fink | M. Gunnarsson | T. Frisell | G. Luna | Peter Alping